Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: GB Group CFO ups stake

(Sharecast News) - GB Group revealed on Monday that chief financial officer David Ward had acquired 10,000 ordinary shares in the AIM-listed identity verification and fraud prevention company. Ward, who took over as CFO in July 2021, purchased the shares on Friday at an average price of 230.70p each, for a total value of £23,070.

Following the purchase, Ward has a beneficial holding of 97,000 ordinary GB shares, representing 0.04% of the company's issued share capital.

As of 1635 GMT, GB shares were up 0.60% at 233.60p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Big Technologies (BIG) Director name: Morris,Daren John Amount purchased: 32,500 @ 191.00p Value: �62,075.00

Gb Group (GBG) Director name: ward,David Amount purchased: 10,000 @ 230.70p Value: �23,070.00

Bbgi Global Infrastructure S.a. Npv (di) (BBGI) Director name: Rosenborg,Jutta af Amount purchased: 8,000 @ 133.60p Value: �10,688.00

Mila Resources (MILA) Director name: Daniels,Lee Amount purchased: 1,212,121 @ 0.83p Value: �10,000.00

Mpac Group (MPAC) Director name: Wilkins,Will Amount purchased: 4,813 @ 207.50p Value: �9,986.98

Jpmorgan Uk Smaller Companies Investment Trust (JMI) Director name: Hart,Katrina Amount purchased: 3,755 @ 264.67p Value: �9,938.17

Keystone Positive Change Investment Trust (KPC) Director name: Hart,Katrina Amount purchased: 4,690 @ 211.87p Value: �9,936.65

Redcentric (RCN) Director name: Brotherton,Peter Amount purchased: 7,020 @ 128.20p Value: �8,999.64

Fusion Antibodies (FAB) Director name: Kinkaid,Adrian Amount purchased: 101,847 @ 4.90p Value: �4,990.50

Fusion Antibodies (FAB) Director name: Douglas,Simon Gordon Amount purchased: 100,565 @ 4.96p Value: �4,988.02

Heiq (HEIQ) Director name: Brade ,Karen Amount purchased: 32,287 @ 15.37p Value: �4,963.16

Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 13,580 @ 23.65p Value: �3,211.67

Top Director Sells

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 37,329 @ $101.23 Value: $3,116,034.30

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 27,945 @ $101.23 Value: $2,332,705.90

Taseko Mines Limited Npv (di) (TKO) Director name: McDonald,Stuart Amount sold: 100,000 @ $1.67 Value: $137,709.24

Maxcyte (di) (MXCT) Director name: Doerfler ,Doug Amount sold: 5,350 @ $5.00 Value: $22,069.25

(ITH) Director name: Myerson,Gilad Amount sold: 1,822,286 @ 1.00p Value: �18,222.86

Share this article

Related Sharecast Articles

Director dealings: Vodafone non-executive director snaps up shares
(Sharecast News) - Vodafone revealed on Thursday that non-executive director Simon Segars had acquired 50,000 ordinary shares in the FTSE 100-listed telecommunications giant.
Director dealings: Robert Walters non-executive director picks up stake
(Sharecast News) - Robert Walters revealed on Wednesday that non-executive director Andrew Rashbass had acwuired 21,739 ordinary shares in the London-listed recruitment company.
Director dealings: Centrica director snaps up shares
(Sharecast News) - Centrica revealed on Tuesday that non-executive director Alessandra Pasini had acquired 26,000 ordinary shares in the FTSE 100-listed energy and services firm.
Director dealings: Mears Group CFO makes share sale
(Sharecast News) - Mears Group revealed on Monday that chief financial officer Andrew Smith had disposed of 108,303 ordinary shares in the London-listed housing and social care provider.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.